Isolated hepatic perfusion: experimental evidence and clinical utility (Q33200876)

23 July 2017

1 reference

title

Isolated hepatic perfusion: experimental evidence and clinical utility (English)

1 reference

23 July 2017

4

Alexander M M Eggermont

1 reference

23 July 2017

Johannes H W de Wilt

1

1 reference

23 July 2017

Boudewijn van Etten

series ordinal

2

1 reference

23 July 2017

Cornelis Verhoef

series ordinal

3

1 reference

23 July 2017

publication date

1 April 2004

1 reference

Surgical Clinics of North America

23 July 2017

published in

1 reference

23 July 2017

volume

84

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

627-641

1 reference

Surgical treatment of liver metastases

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Hepatic-arterial chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Hepatic artery chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Percutaneous alcohol ablation for liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated liver perfusion for non-resectable liver tumours: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Studies on the isolated perfused pig liver

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Hyperthermic isolation-perfusionin vivo of the canine liver

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolation-perfusion of the liver with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

A successful technique of in vivo isolated liver perfusion in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hyperthermic liver perfusion with high dose tumor necrosis factor alpha in pigs: an experimental study in preparation of clinical Use

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

High mitomycin C concentration in tumour tissue can be achieved by isolated liver perfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

A technique for isolated liver perfusion in the rat with survival and results of cytotoxic drug perfusion on liver tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Tumor and liver drug uptake following hepatic artery and portal vein infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Vascularization of small liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Tumoricidal effects and patient survival after hyperthermic liver perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

[Isolated liver perfusion in advanced metastases of colorectal cancers]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

First experience and technical aspects of isolated liver perfusion for extensive liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2803%2900233-0

7 January 2021

10.1016/S0039-6109(03)00233-0

Identifiers

DOI

1 reference

23 July 2017

1 reference